Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. - Wikidata - wikimedia - TriplyDB

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes.

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes.

http://www.wikidata.org/entity/Q44559076

about

Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications The interplay of autoimmunity and insulin resistance in type 1 diabetes Insulin sensitivity and complications in type 1 diabetes: New insights Early diabetic nephropathy in type 1 diabetes: new insights Interaction between advanced glycation end products formation and vascular responses in femoral and coronary arteries from exercised diabetic rats Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM).Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms.Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successful combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver.Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus.Low serum adiponectin levels in children and adolescents with diabetic retinopathy Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance.Intramyocellular lipid and insulin resistance: differential relationships in European and African Americans.Longitudinal Analysis of Adiponectin through 20-Year Type 1 Diabetes Duration.Insulin resistance and associated factors in patients with Type 1 Diabetes.Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays.Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy Features of hepatic and skeletal muscle insulin resistance unique to type 1 diabetes.Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes.The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes.Modulation of lupus phenotype by adiponectin deficiency in autoimmune mouse models The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes Adiponectin promotes functional recovery after podocyte ablation.Adiponectin and leptin: potential tools in the differential diagnosis of pediatric diabetes?Cohort profile: the German Diabetes Study (GDS).Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?Skeletal muscle fat infiltration: impact of age, inactivity, and exercise.Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes.Adiponectin deficiency modulates adhesion molecules expression and cytokine production but does not affect disease severity in the transfer model of colitis.Addressing insulin resistance in Type 1 diabetes.Effects of type 1 diabetes mellitus on skeletal muscle: clinical observations and physiological mechanisms.Cardiovascular risk in double diabetes mellitus--when two worlds collide.The broad clinical phenotype of Type 1 diabetes at presentation.S-allylcysteine Improves Streptozotocin-Induced Alterations of Blood Glucose, Liver Cytochrome P450 2E1, Plasma Antioxidant System, and Adipocytes Hormones in Diabetic Rats Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes.

P2860

Q26775403-C19EB8ED-8DF7-45AC-A204-1852AAEAF6CE Q26823862-98293D8E-ADE6-4423-89B6-8665C9252610 Q27000205-AA451E11-278F-4135-BB27-2F62A710BA18 Q27021632-619C1C96-DF32-413A-AFDC-2D5CA164135C Q27322359-DD5E222D-4EE2-48C0-A68F-EE1FEC33EB77 Q30434577-4DF521E3-5C20-4EAB-9A93-0288137A4687 Q33552031-29C189CD-81C8-463A-BBDC-18DECCED2D87 Q33556535-00A7BE3E-89AF-41ED-8CC4-ADB9F94E19EC Q33736145-3BD18E35-09A9-4E58-9279-F30207727F49 Q33771752-49BFB51B-E6FD-48D3-B04B-43FCB95D9CE3 Q33930217-AE4A5D0B-24B0-4FC5-8A3E-80C97E93141F Q33930299-ABECBBBF-95FE-46D5-A011-21F6EA96C02B Q34081572-5DA4D165-24F0-4B3C-9F07-60AB44473B09 Q34336580-6AD2FBCC-E3B5-432D-8802-CF0AB15FEE89 Q34666575-4B8A93F2-784C-4D20-88B6-65DD006E79B0 Q35004291-CA48879F-D056-4C84-A74F-7EC26C2CB005 Q35209779-6E5E7983-E711-43CD-BC6B-3813626DFEF7 Q35531487-299E24DD-DFB2-423F-8EE0-7FE575AFB15C Q35559139-72D5A7F8-319A-4150-932E-7BA8FC4FCA89 Q35579643-F3D71090-B7B0-41F6-817C-0D6760631718 Q35673446-5E03E7CA-4A8A-45B3-8D62-ABE1F1F42584 Q35921374-01AA7CE0-A301-4164-93DF-4081B3D72BA0 Q36091431-A60656ED-A947-41F4-9D6C-A0C4FA3FEAC1 Q36404490-B0D8C7EA-51F6-4EE9-B6D5-54A6DB3FBDC3 Q36404495-6D4C1719-DE84-46F5-AA35-111E01364A97 Q36419531-B1EF48B9-D643-4B7B-80CD-F1BA82281BDD Q36508961-C3562B1D-FD1D-4E1F-B6CA-6B3C8FB3B262 Q36574746-10EB9C5F-1BB0-4E50-B30C-0D5D159105A0 Q36666515-FFF54D5A-AAE9-40C8-97FD-4F6B3A37BA1F Q36774677-40A4ABA5-79C6-4FA2-A744-81A2FEFF2D89 Q36898042-5F0EC9B1-EF87-4F88-BE6C-AFFE349DFBF8 Q37134834-C84DC1C2-03C9-4609-9F2A-69A78098688A Q37278013-4CE55B96-4AF3-457C-89F5-2EC83A4B1307 Q37368285-17B3D015-C421-4828-BE31-732280AE87C6 Q37381806-4218AB8F-DBCA-4857-9E8E-A5850BDCC6DB Q37791182-56E15000-E554-4B00-A212-2B9147603D16 Q38001360-03D7CD55-2315-446B-828C-F3F7098F71BB Q38052934-8582D4A2-D6F0-446A-982F-C6CB85080F9C Q38549688-B743F1B1-7298-444A-8BD7-8A697C556C6C Q38642435-0F14BFC4-4AB4-4386-A500-9CE435D7B879

P2860

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes.

http://www.wikidata.org/entity/Q44559076

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@en

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@nl

type

label

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@en

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@nl

prefLabel

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@en

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@nl

P1433

Q44559076-85A27EA3-C839-4465-9986-44789C620023

P1476

Q44559076-1BE56E6C-EC59-42B1-8D18-FF6A09895B6D

P2093

Q44559076-0A56FA1B-B848-407F-9DF0-890A907A196D

Q44559076-0F087662-2B1F-4D9A-A776-3607405CE551

Q44559076-16E76DBE-2F54-490E-8885-8AE3D3F52F70

Q44559076-2148F1DE-81C7-46D7-AECB-797EC04D04B9

Q44559076-2A09F5DC-CD36-4B95-83C6-C5D57D7449CD

Q44559076-38EA0C65-B79B-4A41-8F25-11CC62611E85

Q44559076-581B5010-C42C-45DE-82A5-22323674B7A8

Q44559076-B0B29127-6598-42DF-93BF-DF955A48472A

Q44559076-CB6BFBE5-A48F-46B4-A288-3043BCF1AAB7

Q44559076-D1610051-6839-4A19-9C6B-994577DC5E31

P2860

Q44559076-0474D9FB-A59B-4D21-BEA2-C56D8420A05A

Q44559076-092AD11D-AF64-468D-804D-DA1C559C5947

Q44559076-1678DB31-997F-4B66-8633-5C41C89EAB7E

Q44559076-1F897977-7D2F-4980-BC01-FA96954A5380

Q44559076-25D18303-6338-4C07-8682-7DF646F10D94

Q44559076-2784FBF8-7D4C-4DA3-BF4A-538366319322

Q44559076-2C0E9EC7-DFCD-4299-B185-484EF668F216

Q44559076-342B9479-080A-4596-BF7B-383A77038DB1

Q44559076-391C3BC0-E02F-4088-A94B-C62D16552BDD

Q44559076-3C9B0162-538A-4C21-AD94-FEC2F1E0D1DF

P304

Q44559076-040834B4-C7DA-4802-B279-63C654C319DB

P31

Q44559076-9016E5B6-F1B9-4D40-8523-FDF55D853EB6

P356

Q44559076-D2E21348-9B1A-43CA-B955-08BF53030D47

P433

Q44559076-28D95248-1A1F-46A0-BD2B-527D1138AC95

P478

Q44559076-D913C2FA-0279-4484-968D-EE91F536D8CB

P577

Q44559076-E0E83605-3F9C-4534-93A2-B7775715FAE0

P5875

Q44559076-71AEBBE1-1334-445C-8C8F-7730AA297CD7

P698

Q44559076-6E9DC182-4434-43AC-A566-FC53F64664CC

P921

Q44559076-3CD69881-8B77-4423-9F56-2909A1E226B9

Q44559076-755791D6-F186-4E85-8AE1-B1AEC486513B

Q44559076-DFFE382C-25CA-41CE-B9FB-46CCA8596978

P356

AJPENDO.00279.2003

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Insulin resistance, intramyoce ...... patients with type 1 diabetes.

@en

P2093

Alberto Battezzati

http://www.w3.org/2001/XMLSchema#string

Alessandro Del Maschio

http://www.w3.org/2001/XMLSchema#string

Antonio Secchi

http://www.w3.org/2001/XMLSchema#string

Francesco De Cobelli

http://www.w3.org/2001/XMLSchema#string

Gianluca Perseghin

http://www.w3.org/2001/XMLSchema#string

Guido Lattuada

http://www.w3.org/2001/XMLSchema#string

Livio Luzi

http://www.w3.org/2001/XMLSchema#string

Lucia Piceni Sereni

http://www.w3.org/2001/XMLSchema#string

Massimo Danna

http://www.w3.org/2001/XMLSchema#string

Paola Maffi

http://www.w3.org/2001/XMLSchema#string

P2860

Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

Cellular mechanisms of insulin resistance

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.

Fatty acid oxidation and the regulation of malonyl-CoA in human muscle.

DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells.

The perils of portliness: causes and consequences of visceral adiposity.

P304

E1174-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00279.2003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10602146

http://www.w3.org/2001/XMLSchema#string

P698

12933352

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes